Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Laura Kairevice"'
Autor:
Laura Kairevičė, Tadas Latkauskas, Algimantas Tamelis, Aleksandras Petrauskas, Henrikas Paužas, Tadas Žvirblis, Laimonas Jaruševičius, Žilvinas Saladžinskas, Dainius Pavalkis, Rasa Jančiauskienė
Publikováno v:
Medicina, Vol 53, Iss 3, Pp 150-158 (2017)
Background and objective: At present, there are common recommendations for treatment for stage II–III resectable rectal cancer patients: preoperative conventional chemoradiotherapy (CRT) with delayed surgery in 6–8 weeks or preoperative short-cou
Externí odkaz:
https://doaj.org/article/c2c2091a219342e1a496365e97b79b93
Autor:
Mingaile Drevinskaite, Ausvydas Patasius, Marius Kincius, Justinas Jonušas, Adomas Ladukas, Mindaugas Jievaltas, Laura Kairevice, Giedre Smailyte
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Background and objectivesThe aim of this study was to analyse trends in penile cancer incidence, mortality, and relative survival in Lithuania during the period of 1998–2017.Materials and methodsThe study was based on all cases of penile cancer rep
Externí odkaz:
https://doaj.org/article/8212c087dfdb47348ff0300f006db0cb
Autor:
Henrikas Pauzas, Ugne Gyvyte, Tadas Latkauskas, Laura Kairevice, Paulius Lizdenis, Saulius Svagzdys, Erika Birgiolaite, Irma Kuliaviene, Juozas Kupcinskas, Algimantas Tamelis
Publikováno v:
Medicina, Vol 56, Iss 4, p 192 (2020)
Background and objectives: The effectiveness of neoadjuvant therapy, which is commonly used for stage II-III rectal cancer (RC) treatment, is limited. Genes associated with the pathogenesis of RC could determine response to this treatment. Therefore,
Externí odkaz:
https://doaj.org/article/7ac23478add14b5aa147d570495b947f
Autor:
Paulius Lizdenis, Erika Birgiolaite, Juozas Kupcinskas, Saulius Svagzdys, Irma Kuliaviene, Algimantas Tamelis, Ugne Gyvyte, Tadas Latkauskas, Laura Kairevice, Henrikas Pauzas
Publikováno v:
Medicina
Volume 56
Issue 4
Medicina; Volume 56; Issue 4; Pages: 192
Medicina, Kaunas ; Basel : LSMU ; MDPI, 2020, vol. 56, no. 4, 192, p. 1-12
Medicina, Vol 56, Iss 192, p 192 (2020)
Volume 56
Issue 4
Medicina; Volume 56; Issue 4; Pages: 192
Medicina, Kaunas ; Basel : LSMU ; MDPI, 2020, vol. 56, no. 4, 192, p. 1-12
Medicina, Vol 56, Iss 192, p 192 (2020)
Background and objectives: The effectiveness of neoadjuvant therapy, which is commonly used for stage II-III rectal cancer (RC) treatment, is limited. Genes associated with the pathogenesis of RC could determine response to this treatment. Therefore,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa41b7090e0770015f84fd88ca537971
Autor:
Algimantas Tamelis, Tadas Latkauskas, Aleksandras Petrauskas, Dainius Pavalkis, Jurate Gudaityte, Laura Kairevice, Rasa Janciauskiene, Henrikas Pauzas, Zilvinas Saladzinskas, Paulius Lizdenis, Saulius Svagzdys
Publikováno v:
BMC Cancer
Background There still is no evidence which neoadjuvant therapy regimen for stage II–III rectal cancer is superior. The aim of this study was to compare results achieved after long-course chemoradiotherapy (CRT) with short-term radiotherapy (RT) fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfb046e86dd292aa8adfb5c3f7946561
https://doi.org/10.1186/s12885-016-2959-9
https://doi.org/10.1186/s12885-016-2959-9